{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:33:29Z","timestamp":1781303609577,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10067-013-2330-3","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T15:53:36Z","timestamp":1373903616000},"page":"1619-1626","source":"Crossref","is-referenced-by-count":51,"title":["Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity"],"prefix":"10.1007","volume":"32","author":[{"given":"Sladjana","family":"Andrejevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Jeremic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Sefik-Bukilica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Stojimirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Bonaci-Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"2330_CR1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI117371","volume":"94","author":"C Kramers","year":"1994","unstructured":"Kramers C, Hylkema MN, Vanbruggen MCJ, Vandelagemaat R, Dijkman HBPM, Assmann KJM, Smeenk RJT, Berden JHM (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular-basement-membrane in-vivo. J Clin Invest 94:568\u2013577","journal-title":"J Clin Invest"},{"key":"2330_CR2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJM199805073381906","volume":"338","author":"BH Hahn","year":"1998","unstructured":"Hahn BH (1998) Antibodies to DNA. N Eng J Med 338:1359\u20131368","journal-title":"N Eng J Med"},{"key":"2330_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002281-200009000-00003","volume":"12","author":"Z Amoura","year":"2000","unstructured":"Amoura Z, Koutouzov S, Piette JC (2000) The role of nucleosomes in lupus. Curr Opin Rheumatol 12:369\u2013373","journal-title":"Curr Opin Rheumatol"},{"key":"2330_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08916939209146131","volume":"12","author":"JP Viard","year":"1992","unstructured":"Viard JP, Choquette D, Chabre H, Slama FB, Primo J, Letrait M, Venot A, Jacob L (1992) Anti-histone reactivity in systemic lupus erythematosus sera: a disease activity index linked to the presence of DNA: anti-DNA immune complexes. Autoimmunity 12:61\u201368","journal-title":"Autoimmunity"},{"key":"2330_CR5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s10067-005-0110-4","volume":"25","author":"P Hor\u00e1k","year":"2006","unstructured":"Hor\u00e1k P, He\u0159manov\u00e1 Z, Zadra\u017eil J, Cifersk\u00e1 H, Ordeltov\u00e1 M, Kus\u00e1 L, \u017durek M, Tich\u00fd T (2006) C1q complement component and antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 25:532\u2013536","journal-title":"Clin Rheumatol"},{"key":"2330_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.trsl.2010.07.009","volume":"156","author":"CC Mok","year":"2010","unstructured":"Mok CC, Ho LY, Leung HW, Wong LG (2010) Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res 156:320\u2013325","journal-title":"Transl Res"},{"key":"2330_CR7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1191\/0961203302lu311rr","volume":"11","author":"LE Schiffer","year":"2002","unstructured":"Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, Davidson A (2002) Lowering anti-dsDNA antibodies\u2013what\u2019s new? Lupus 11:885\u2013894","journal-title":"Lupus"},{"key":"2330_CR8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1191\/0961203302lu300rr","volume":"11","author":"D Isenberg","year":"2002","unstructured":"Isenberg D, Smeenk R (2002) Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus 11:797\u2013800","journal-title":"Lupus"},{"key":"2330_CR9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rithfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"2330_CR10","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288\u2013291","journal-title":"J Rheumatol"},{"key":"2330_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2009.04650.x","volume":"1173","author":"N Villegas-Zambrano","year":"2009","unstructured":"Villegas-Zambrano N, Mart\u00ednez-Taboada VM, Bol\u00edvar A, San Martin M, Alvarez L, Marin MJ, L\u00f3pez-Hoyos M (2009) Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study. Ann NY Acad Sci 1173:60\u201366","journal-title":"Ann NY Acad Sci"},{"key":"2330_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1191\/096120300678828082","volume":"9","author":"E Toubi","year":"2000","unstructured":"Toubi E, Rosner I, Rozenbaum M, Kessel A, Golan TD (2000) The benefit of combining hydroxychloroquine and quinacrine in the treatment of SLE patients. Lupus 9:92\u201395","journal-title":"Lupus"},{"key":"2330_CR13","first-page":"13","volume":"20","author":"D-J Min","year":"2002","unstructured":"Min D-J, Kim S-J, Park S-H, Seo Y-I, Kang H-J, Kim W-U, Cho C-S, Kim H-Y (2002) Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheum 20:13\u201318","journal-title":"Clin Exp Rheum"},{"key":"2330_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1191\/096120399680411281","volume":"8","author":"M Petri","year":"1999","unstructured":"Petri M, Buyon J, Kim M (1999) Classification and definition of major flares in SLE clinical trials. Lupus 8:685\u201391","journal-title":"Lupus"},{"key":"2330_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.1780220304","volume":"22","author":"AJ Swaak","year":"1979","unstructured":"Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22:226\u2013235","journal-title":"Arthritis Rheum"},{"key":"2330_CR16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1191\/0961203303lu1015oa","volume":"13","author":"JD Reveille","year":"2004","unstructured":"Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290\u2013297","journal-title":"Lupus"},{"key":"2330_CR17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1191\/0961203305lu2130oa","volume":"14","author":"M L\u00f3pez-Hoyos","year":"2005","unstructured":"L\u00f3pez-Hoyos M, Cabeza R, Mart\u00ednez-Taboada VM, Crespo J, SanSegundo D, Blanco R, L\u00f3pez-Escribano H, Pe\u00f1a M, Rodrigez-Valverde V (2005) Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 14:505\u2013509","journal-title":"Lupus"},{"key":"2330_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/0961203303lu331oa","volume":"12","author":"C-Y Chen","year":"2003","unstructured":"Chen C-Y, Tseng H-M, Chen L-C, Tsao C-H, Kuo M-L, Ou L-S, Huang J-L (2003) Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients. Lupus 12:266\u2013273","journal-title":"Lupus"},{"key":"2330_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1172\/JCI108626","volume":"59","author":"JB Winfield","year":"1977","unstructured":"Winfield JB, Faiferman I, Koffler D (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 59:90\u201396","journal-title":"J Clin Invest"},{"key":"2330_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1191\/0961203303lu277oa","volume":"12","author":"D Villalta","year":"2003","unstructured":"Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, Tonutti E, Ghirardello A, Doria A (2003) Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 12:31\u201336","journal-title":"Lupus"},{"key":"2330_CR21","first-page":"50","volume":"29","author":"A Ghirardello","year":"2011","unstructured":"Ghirardello A, Villalta D, Morozzi G et al (2011) Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheum 29:50\u201356","journal-title":"Clin Exp Rheum"},{"key":"2330_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1191\/0961203306lu2308oa","volume":"15","author":"HP Jaekel","year":"2006","unstructured":"Jaekel HP, Trabandt A, Grobe N, Werle E (2006) Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus 15:335\u2013345","journal-title":"Lupus"},{"key":"2330_CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cca.2007.02.010","volume":"380","author":"KH Kim","year":"2007","unstructured":"Kim KH, Han JY, Kim JM, Lee SW, Chung WT (2007) Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Clin Chim Acta 380:182\u2013185","journal-title":"Clin Chim Acta"},{"key":"2330_CR24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0961203310362995","volume":"19","author":"A Antico","year":"2010","unstructured":"Antico A, Platzgummer S, Bassetti D, Bizzaro N, Tozzoli R, Villalta D (2010) Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus 19:906\u2013912","journal-title":"Lupus"},{"key":"2330_CR25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0961203310369681","volume":"19","author":"F Fiegel","year":"2010","unstructured":"Fiegel F, Buhl A, Jaekel HP, Werle E, Schmolke M, Ollert M, Luppa PB (2010) Autoantibodies to double-stranded DNA\u2014intermethod comparison between four commercial immunoassays and a research biosensor-based device. Lupus 19:957\u2013964","journal-title":"Lupus"},{"key":"2330_CR26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1373\/clinchem.2004.037960","volume":"50","author":"J-C Wasmuth","year":"2004","unstructured":"Wasmuth J-C, Gr\u00fcn B, Homrighausen A, Spangler U (2004) ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus. Clin Chem 50:2169\u20132171","journal-title":"Clin Chem"},{"key":"2330_CR27","first-page":"51","volume":"24","author":"S Saisoong","year":"2006","unstructured":"Saisoong S, Eiam-Ong S, Hanvivatvong O (2006) Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol 24:51\u201358","journal-title":"Clin Exp Rheumatol"},{"key":"2330_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clim.2006.10.003","volume":"122","author":"Y Su","year":"2007","unstructured":"Su Y, Jia RL, Han I, Li ZG (2007) Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol 122:115\u2013120","journal-title":"Clin Immunol"},{"key":"2330_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2003.12.005","volume":"22","author":"A Ghirardello","year":"2004","unstructured":"Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccolo A, Gambari PF (2004) Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 22:235\u2013240","journal-title":"J Autoimmun"},{"key":"2330_CR30","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/ar2831","volume":"11","author":"JJ Manson","year":"2009","unstructured":"Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D\u2019Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154","journal-title":"Arthritis Res Ther"},{"key":"2330_CR31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10067-009-1130-2","volume":"28","author":"AA Shabana","year":"2009","unstructured":"Shabana AA, El-Ghawet AE, Machaly SA, Abu Hashim EM (2009) Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus. Clin Rheumatol 28:673\u2013678","journal-title":"Clin Rheumatol"},{"key":"2330_CR32","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/40.12.1405","volume":"40","author":"CT Ravirajan","year":"2001","unstructured":"Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA (2001) An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 40:1405\u20131412","journal-title":"Rheumatology (Oxford)"},{"key":"2330_CR33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1191\/0961203302lu247oa","volume":"11","author":"G Schett","year":"2002","unstructured":"Schett G, Smolen J, Zimmermman C, Hiesberger H, Hoefler E, Fournel S, Muller S, Rubin RL, Steiner G (2002) The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are highly specific marker for SLE associated with increased disease activity. Lupus 11:704\u2013715","journal-title":"Lupus"},{"key":"2330_CR34","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","volume":"32","author":"AJ Nauta","year":"2002","unstructured":"Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ, Gingras AR, Mantovani A, Hack EC, Roos A (2002) Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32:1726\u20131736","journal-title":"Eur J Immunol"},{"key":"2330_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molimm.2006.06.010","volume":"44","author":"R Flierman","year":"2007","unstructured":"Flierman R, Daha MR (2007) Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis\u2014a hypothesis. Mol Immunol 44:133\u2013138","journal-title":"Mol Immunol"},{"key":"2330_CR36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI200421075","volume":"114","author":"LA Trouw","year":"2004","unstructured":"Trouw LA, Groeneveld TW, Seelen MA, Dujis JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verebeek JS, van Kooten C, Daha MR (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679\u2013688","journal-title":"J Clin Invest"},{"key":"2330_CR37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1749-6632.2009.04750.x","volume":"1173","author":"A Tsirogianni","year":"2009","unstructured":"Tsirogianni A, Pipi E, Soufleros K (2009) Relevance of anti-C1q autoantibodies to lupus nephritis. Ann NY Acad Sci 1173:243\u2013251","journal-title":"Ann NY Acad Sci"},{"key":"2330_CR38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10067-003-0724-3","volume":"22","author":"P Oelzner","year":"2003","unstructured":"Oelzner P, Deliyska B, F\u00fcnfst\u00fcck R, Hein G, Herrmann D, Stein G (2003) Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus\u2014relationship with disease activity and renal involvement. Clin Rheumatol 22:271\u2013278","journal-title":"Clin Rheumatol"},{"key":"2330_CR39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molimm.2011.07.020","volume":"49","author":"J O\u2019Flynn","year":"2011","unstructured":"O\u2019Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR (2011) Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol Immunol 49:75\u201383","journal-title":"Mol Immunol"},{"key":"2330_CR40","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar2725","volume":"11","author":"OC Mayer","year":"2009","unstructured":"Mayer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieud\u00e9 P, Chollet-Martin S (2009) Anti-C1q antibodies antedate patient active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ter 11:R87","journal-title":"Arthritis Res Ter"},{"key":"2330_CR41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.10558","volume":"47","author":"AF Kavanaugh","year":"2002","unstructured":"Kavanaugh AF, Solomon DH (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum (Arthritis Care and Research) 47:546\u2013555","journal-title":"Arthritis Rheum (Arthritis Care and Research)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2330-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2330-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2330-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:27Z","timestamp":1559120247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2330-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2330"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2330-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}